EXPONENTIAL GROWTH4 Dec 2025 09:36
Before full US regulatory clearance, laboratories will be offered the test as a Lab Developed Test, a route that allows hospitals and clinics to run their own versions while the food and drug regulator completes its review.
Once GENinCode secures FDA medical-device approval, Thermo Fisher will begin manufacturing and selling the kit directly to laboratories and testing centres. A similar roll-out is planned in EMEA.
The tie-up is significant for a company of GENinCode’s size. Thermo Fisher’s QuantStudio 5 Dx real-time PCR system, on which the test is designed, is already widely installed, giving the test immediate reach. The partners expect to scale manufacturing as demand grows exponentially.